ArticlePloS one2025
Integrated multi-omics analysis and predictive modeling of heart failure using sepsis-related gene signature.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sepsis in multimorbidity: a domain-based framework for systemic vulnerability and precision care.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeart failure (HF) is characterized by complex molecular alterations, and recent studies suggest a potential role for sepsis-related genes in cardiovascular dysfunction. This study aimed to develop a predictive model for HF based on sepsis-related gene signatures.
methodsThree sepsis-related datasets (GSE65682, GSE54514, and GSE95233) were analyzed to identify differentially expressed genes (DEGs) following batch effect correction using the ComBat algorithm. With the use of elastic net regularization and the glmnet package in R, Lasso Cox regression was employed to screen out gene signatures. A predictive model was developed based on the expression of each gene signature and the co-efficient values. In addition, the predictive model was validated on independent HF datasets (GSE57345, GSE141910, and GSE5406). Model performance was assessed through receiver operating characteristic (ROC) analysis and AUC values of each gene signature, and immune infiltration was evaluated using CIBERSORT, IPS, and xCell. Sepsis models of C57BL/6 mice were established by cecal ligation and puncture (CLP).
resultsWe identified 340 up-regulated and 333 down-regulated sepsis-related genes. The predictive model, incorporating six key genes, demonstrated superior performance compared to individual genes across both training and validation datasets with the AUC value of the risk score above 0.9, significantly higher than that of a single gene. Immune infiltration profiles differed significantly between HF patients and controls, with more pronounced alterations observed at higher risk score levels. Finally, the expression of six key genes in sepsis models was confirmed to be consistent with our prediction.
conclusionThe model constructed through sepsis-related characteristic genes provides a highly advantageous method for predicting HF, and the characteristic genes we have screened may be potential biomarkers for predicting HF. This model has potential application value in early diagnosis and risk stratification, which can help improve the clinical management of heart failure and provide new ideas for preventing HF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.